Association of cathepsin L with coronary heart disease and its risk factors

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 2, 2009, Pages 130-134

  Wang, Jun ^a   Liu, Yingxian ^a   Li, Xiangping ^a   Peng, Daoquan ^a   Tan, Zhen ^a   Liu, Hongmin ^a   Qin, Yingnan ^a   Xue, Yanqiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cathepsin l; Coronary heart disease; Coronary stenosis; Risk factors

Indexed keywords

CATHEPSIN L;

ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CATHEPSIN L; CORONARY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 62749175215     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Liu J, Sukhova G K, Yang J T, et al. Cathepsin L expre - ssion and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells [ J ]. Atherosclerosis, 2006,184(2): 302-311.
2. Li W, Yuan X M. Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis [ J ]. Ann N Y Acad Sci, 2004, 1030( 12): 427-433.
3. Urbich C, Heeschen C, Aicher A, et al. Cathepsin L is required for endothelial progenitor cell - induced neovascularization [ J ]. Nat Med, 2005, 1 1 (2): 206-213.
4. Yang M, Zhang Y, Pan J, et al. Cathepsin L activity controls adipogenesis and glucose tolerance [ J ]. Nat Cell Biol, 2007,9 ( 8 ): 970-977.
5. Sofia J, Dirk M W, Allan S, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E - deficient mice [ J ]. Am J Pathol, 2002,161 ( 3 ): 939-945.
6. Kitamoto S, Sukhova G K, Sun J, et al. Cathepsin L deficiency reduces diet - induced atherosclerosis in low - density lipoprotein receptor - knockout mice [ J ]. Circulation, 2007, 1 15 ( 15 ): 2065-2075.
7. Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease [J ]. Am J Cardiol, 1983,51 (2 ): 606.
8. LIU Yusheng, LU Qinghua, JIANG Weidong. Cathepsins and extracellular matrix remodeling [ J ]. Basic & Clinical Medicine, 2006,26(9): 1037-1040.
9. Fach E M, Garulacan L A, Gao J, et al. In vitro biomarker discovery for atherosclerosis by proteomics [ J ]. Mol Cell Pro- teomics,2004,3 ( 12 ): 1200-1210.
10. Yang M, Zhang Y, Pan J, et al. Cathepsin L activity controls adipogenesis and glucose tolerance [ J ]. Nat Cell Biol, 2007,9 ( 8 ):970-977.
11. Lindstedt L, Lee M, Oomi K, et al. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells [ J ]. Biochem Biophys Res Commun,2003,312(4): 1019-1024.
12. Lutgens S P, Cleutjens K B, Daemen M J, et al. Cathepsin cysteine proteases in cardiovascular disease [ J ]. FASEB J, 2007,21 ( 12 ): 3029-3041.